Patent · US Active

Anti-lag-3 antibody polypeptide

US11661452B2 · kind B2 · utility

1Cited by
11References
22Claims
0Family size

Assignees

Inventors

Key dates

Filing dateMar 15, 2019
Grant dateMay 30, 2023
Priority date
Expiry dateAug 14, 2039

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/70503
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present disclosure provides anti-LAG-3 heavy-chain antibody or the antigen-binding domain thereof, isolated polynucleotides encoding the same, pharmaceutical compositions comprising the same, and the uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.